← Back to headlines
Merck's Oral PCSK9 Enlicitide Demonstrates Superior Cholesterol Lowering
Merck's oral PCSK9 enlicitide has shown improved cholesterol-lowering capabilities when compared to non-statin treatments.
30 Mar, 18:54 — 30 Mar, 18:54
Sources
Showing 1 of 1 sources
